Moody National Bank Trust Division’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,145
Closed -$325K 596
2023
Q3
$325K Sell
3,145
-330
-9% -$36.8K 0.02% 486
2023
Q2
$422K Hold
3,475
0.03% 430
2023
Q1
$534K Sell
3,475
-280
-7% -$46.2K 0.05% 349
2022
Q4
$674K Buy
3,755
+181
+5% +$29.6K 0.06% 271
2022
Q3
$423K Buy
3,574
+77
+2% +$11.7K 0.04% 363
2022
Q2
$500K Buy
+3,497
New +$500K 0.05% 283

Other funds holding MRNA

Moody National Bank Trust Division's MRNA Position: Q4 2023 in Review

Moody National Bank Trust Division sold out of Moderna (MRNA) in Q4 2023, closing a stake of 3,145 shares — an estimated $325K sold.

Moody National Bank Trust Division first reported a position in MRNA in Q2 2022 and held it in 6 quarters. The position peaked at $674K in Q4 2022. 885 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Moody National Bank Trust Division reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Moody National Bank Trust Division sold 3,145 Moderna shares in Q4 2023, an estimated $325K.
  • Moody National Bank Trust Division first reported a position in Moderna in Q2 2022 and held it in 6 quarters.
  • Moody National Bank Trust Division's Moderna position peaked at $674K in Q4 2022.
  • 885 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Moody National Bank Trust Division's 13F filing for Q4 2023, filed 11 Jan 2024.